Comparative effects of soy phytoestrogens and 17β-estradiol on DNA methylation of a panel of 24 genes in prostate cancer cell lines

Nutrition and Cancer

Volumn 66, Issue 3, 2014, Pages 474-482

  Adjakly, Mawussi ^a,b   Ngollo, Marjolaine ^a,b   Lebert, André ^b   Dagdemir, Aslihan ^a,b   Penault Llorca, Frédérique ^a,b   Boiteux, Jean Paul ^c   Bignon, Yves Jean ^a,b   Guy, Laurent ^b,c   Bernard Gallon, Dominique ^a,b  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; BUDESONIDE; DAIDZEIN; ESTRADIOL; GENISTEIN; ESTROGEN RECEPTOR BETA; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN;

APC GENE; APOPTOSIS; AR GENE; ARTICLE; CANCER CELL CULTURE; CAV1 GENE; CCNA1 GENE; CDH1 GENE; CDKN2A GENE; CELL PROLIFERATION; CELL STRAIN LNCAP; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DDK3 GENE; DEMETHYLATION; DLC1 GENE; DNA METHYLATION; DRUG EFFECT; DRUG MECHANISM; EDNRB GENE; GENE; GPX3 GENE; GSTP1 GENE; HSA MIR 34A GENE; HUMAN; HUMAN CELL; MGMT GENE; MSX1 GENE; OPCML GENE; PANEL STUDY; PDLIMA GENE; PROMOTER REGION; PROSTATE CANCER; PTGS2 GENE; RAR BETA GENE; RASSF1A GENE; SFRP1 GENE; SLC5A8 GENE; TIMP2 GENE; TNFRSF10D GENE; TUMOR GENE; ZNF185 GENE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PROSTATIC NEOPLASMS; SOYBEAN; TUMOR CELL LINE;

AZACITIDINE; BUDESONIDE; CELL LINE, TUMOR; DNA METHYLATION; ESTRADIOL; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; ISOFLAVONES; MALE; PHYTOESTROGENS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; SOYBEANS;

EID: 84897452154     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2014.884236     Document Type: Article

References (30)

1. Yan L and Spitznagel EL: Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 117, 667-669, 2005. (Pubitemid 41504557)
2. Magee PJ and Rowland IR: Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91, 513-531, 2004. (Pubitemid 38584776)
3. Hedlund TE, Johannes WU, and Miller GJ: Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate 54, 68-78, 2003. (Pubitemid 36043838)
4. Hsu A, Bray TM, Helferich WG, Doerge DR, and Ho E: Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells. Exp Biol Med (Maywood) 235, 90-97, 2010.
5. Rabiau N, Kossai M, Braud M, Chalabi N, Satih S, et al.: Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by polymerase chain reaction arrays in human prostate cancer cell lines. Cancer Epidemiol 34, 200-206, 2010.
6. Carvalho JR, Filipe L, Costa VL, Ribeiro FR, Martins AT, et al.: Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer. Apoptosis 15, 956-965, 2010.
7. Yang M and Park JY: DNA methylation in promoter region as biomarkers in prostate cancer. Methods Mol Biol 863, 67-109, 2012.
8. Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, et al.: Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-cell translocation gene 3 in prostate cancer. Cancer 116, 66-76, 2010.
9. Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, et al.: Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modifi-cation. Cancer Res 68, 2736-2744, 2008. (Pubitemid 351556271)
10. Adjakly M, Bosviel R, Rabiau N, Boiteux JP, Bignon YJ, et al.: DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines. Epigenomics 3, 795-803, 2011.
11. Vardi A, Bosviel R, Rabiau N, Adjakly M, Satih S, et al.: Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In Vivo 24, 393-400, 2010.
12. Chen Z, Katzenellenbogen BS, Katzenellenbogen JA, and Zhao H: Directed evolution of human estrogen receptor variants with significantly enhanced androgen specificity and affinity. J Biol Chem 279, 33855-33864, 2004. (Pubitemid 39063035)
13. Fox EM, Andrade J, and ShupnikMA: Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. Steroids 74, 622-627, 2009.
14. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, et al.: Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J Cell Physiol 203, 193-201, 2005. (Pubitemid 40330938)
15. Koehler KF, Helguero LA, Haldosen LA, Warner M, and Gustafsson JA: Reflections on the discovery and significance of estrogen receptor beta. Endocr Rev 26, 465-478, 2005. (Pubitemid 40691301)
16. Mueller SO, Simon S, Chae K, Metzler M, and Korach KS: Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 80, 14-25, 2004. (Pubitemid 38967392)
17. Qian Z, Chen L, Fernald AA, Williams BO, and Le Beau MM: A critical role for Apc in hematopoietic stem and progenitor cell survival. J ExpMed 205, 2163-2175, 2008.
18. Liu L, Kron KJ, Pethe VV, Demetrashvili N, Nesbitt ME, et al.: Association of tissue promoter methylation levels of APC, TGFbeta2, HOXD3 and RASSF1A with prostate cancer progression. Int J Cancer 129, 2454-2462, 2011.
19. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, et al.: Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7, 2591-2600, 2008.
20. Yamanaka M,Watanabe M, Yamada Y, Takagi A, Murata T, et al.: Altered methylation ofmultiple genes in carcinogenesis of the prostate. Int J Cancer 106, 382-387, 2003. (Pubitemid 36870401)
21. Lau KM, LaSpina M, Long J, and Ho SM: Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res 60, 3175-3182, 2000. (Pubitemid 30407914)
22. Pravettoni A, Mornati O, Martini PG, Marino M, Colciago A, et al.: Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: studies on the possible mechanism of action in DU145 cells. Mol Cell Endocrinol 263, 46-54, 2007. (Pubitemid 44828230)
23. Hagemann S, Heil O, Lyko F, and Brueckner B: Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines. PLoS One 6, e17388, 2011.
24. PereiraMA, Tao L, Liu Y, Li L, Steele VE, et al.:Modulation by budesonide of DNA methylation and mRNA expression in mouse lung tumors. Int J Cancer 120, 1150-1153, 2007. (Pubitemid 46214320)
25. Lai JC, Wu JY, Cheng YW, Yeh KT, Wu TC, et al.: O6-Methylguanine-DNA methyltransferase hypermethylation modulated by 17beta-estradiol in lung cancer cells. Anticancer Res 29, 2535-2540, 2009.
26. Bjornstrom L and Sjoberg M: Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19, 833-842, 2005. (Pubitemid 40397050)
27. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Retrieved from http://www.R-project.org
28. Mendiburu F: agricolae(): Statistical Procedures for Agricultural Research. R package version 1.1.4, 2013. http://tarwi.lamolina.edu.pe/ ∼fmendiburu
29. Heiberger RM: HH(): Statistical Analysis and Data Display. New York, NY: Springer Science, 2013.
30. Torsten H, Bretz F, Westfall P, and Heiberger RM: Multcomp(): Simultaneous Inference in General Parametric Models. Biometrical Journal 50, 346-363, 2014.